OBJECTIVES: to describe the seroprevalence of hepatitis B (HBV) and C (HCV) infection in HIV-positive and HIV-negative pregnant women from rural Malawi. METHODS: descriptive study using serum samples collected between 1993-1995 in the Shire valley in rural Malawi. Fifty HIV-positive and 100 HIV-negative samples were selected randomly from 153 HIV-positive and 443 HIV-negative women delivering in the hospital. RESULTS: evidence of HBV and HCV infection was found in 71.7 and 16.5% of women, respectively. Chronic carriage of HBV (HBsAg positive) is high (13%) and in agreement with prevalences reported from highly endemic areas. Exposure to HBV and HCV probably occurred well before adulthood as the prevalence of anti-HBc antibody was high in young mothers <20 years of age (22/27; 81%). CONCLUSION: HBV and HCV infections are highly endemic in rural Malawi. There was no statistical evidence to suggest that HIV positivity was associated with an increased prevalence of HBV or HCV markers. Infection with HBV or HCV was not statistically associated.
OBJECTIVES: to describe the seroprevalence of hepatitis B (HBV) and C (HCV) infection in HIV-positive and HIV-negative pregnant women from rural Malawi. METHODS: descriptive study using serum samples collected between 1993-1995 in the Shire valley in rural Malawi. Fifty HIV-positive and 100 HIV-negative samples were selected randomly from 153 HIV-positive and 443 HIV-negative women delivering in the hospital. RESULTS: evidence of HBV and HCV infection was found in 71.7 and 16.5% of women, respectively. Chronic carriage of HBV (HBsAg positive) is high (13%) and in agreement with prevalences reported from highly endemic areas. Exposure to HBV and HCV probably occurred well before adulthood as the prevalence of anti-HBc antibody was high in young mothers <20 years of age (22/27; 81%). CONCLUSION: HBV and HCV infections are highly endemic in rural Malawi. There was no statistical evidence to suggest that HIV positivity was associated with an increased prevalence of HBV or HCV markers. Infection with HBV or HCV was not statistically associated.
Authors: Charles S Chasela; Patrick Wall; Jan Drobeniuc; Caroline C King; Eyasu Teshale; Mina C Hosseinipour; Sascha R Ellington; Mary Codd; Denise J Jamieson; Rodney J Knight; Patricia Fitzpatrick; Athena P Kourtis; Irving F Hoffman; Dumbani Kayira; Noel Mumba; Deborah D Kamwendo; Francis Martinson; William Powderly; Charles van der Horst; Saleem Kamili Journal: J Clin Virol Date: 2012-06-02 Impact factor: 3.168
Authors: Rita B Effros; Courtney V Fletcher; Kelly Gebo; Jeffrey B Halter; William R Hazzard; Frances McFarland Horne; Robin E Huebner; Edward N Janoff; Amy C Justice; Daniel Kuritzkes; Susan G Nayfield; Susan F Plaeger; Kenneth E Schmader; John R Ashworth; Christine Campanelli; Charles P Clayton; Beth Rada; Nancy F Woolard; Kevin P High Journal: Clin Infect Dis Date: 2008-08-15 Impact factor: 9.079
Authors: Samir Aoudjane; Mas Chaponda; Antonio Adrián González Del Castillo; Jemma O'Connor; Marc Noguera; Apostolos Beloukas; Mark Hopkins; Saye Khoo; Joep J van Oosterhout; Anna Maria Geretti Journal: Clin Infect Dis Date: 2014-08-06 Impact factor: 9.079
Authors: Ahizechukwu C Eke; Uzoamaka A Eke; Charles I Okafor; Ifeanyichukwu U Ezebialu; Chukwuanugo Ogbuagu Journal: Virol J Date: 2011-01-12 Impact factor: 4.099